Previous Close | 0.0000 |
Open | 0.0001 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0001 - 0.0001 |
52 Week Range | 0.0001 - 0.0086 |
Volume | |
Avg. Volume | 0 |
Market Cap | 10,236 |
Beta (5Y Monthly) | 0.49 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3300 |
Earnings Date | Oct 22, 2024 - Oct 27, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Item 9 Labs Corp. (OTCPK: INLB) ("INLB" or the "Company"), a vertically integrated cannabis operator and dispensary franchisor that produces high-grade, award-winning products has retained Sharp Capital Advisors LLC ("Sharp") to assist in the exploration of a sale of the Company. The Company consists of two core operating businesses, Item 9 Labs and Unity Rd.